2013-02-22 13:52:43 - Recently published research from Business Monitor International, "United Arab Emirates Oil & Gas Report Q1 2013", is now available at Fast Market Research

BMI Industry ViewHeadline Expenditure Projections

* Pharmaceuticals: ILS7.08bn (US$1.98bn) in 2011 to ILS7.44bn (US$1.89bn) in 2012; +5.1% in local currency terms and -4.8% in US dollar terms. Forecast slightly lower from Q412 on account of macroeconomic factors.
* Healthcare: ILS65.73bn (US$18.37bn) in 2011 to ILS69.88bn (US$17.69bn) in 2012; +6.3% in local currency terms and -3.7% in US dollar terms. Forecast slightly lower from Q412 on account of macroeconomic factors.
* Medical devices: ILS3.80bn (US$1.06bn) in 2011 to ILS3.93bn (US$0.99bn) in 2011; +3.2% in local currency terms and -6.5% in US dollar terms. Forecast slightly lower from Q412 on account of macroeconomic factors.

Risk/Reward Rating:

In our latest regional Pharmaceutical Risk Reward Ratings (RRRs), Israel ranks third out of the 30 markets surveyed

in MEA, with an unchanged composite score of 56.4. A largely urbanised population with a significant pensioner proportion and widespread preference for patented medicines are key factors driving multinational investment in the country, although we maintain risks of weak intellectual property laws and long drug approval times to the commercial launch of new medicines will remain high.


Full Report Details at
- www.fastmr.com/prod/536471_israel_pharmaceuticals_healthcare_rep ..


Key Trends And Developments:

November

* Immune Pharmaceuticals and US pharmaceutical company EpiCept Corporation entered a merger agreement to create a new specialty biopharmaceutical company - Immune Pharmaceuticals Incorporation. The company will focus on the development of antibody therapeutics and targeted drugs for the treatment of cancer and inflammatory diseases.
* Six hospitals in East Jerusalem were reported to be experiencing a financial crisis due to the unpaid debt accrued from the Western-backed Palestinian Authority (PA). The PA was unable to meet payments for the hospitals' services to Palestinians in Gaza and the West Bank seeking medical attention and owes US $18mn to specialised healthcare centres.

October

* Israel secured a pharmaceutical trade agreement with the European Union. The European parliament approved the Agreement on Conformity Assessment and Acceptance of Industrial Products which means Israeli products are recognised as having equivalent manufacturing and quality standards to those in the EU and will not require additional analysis and testing before reaching the shelves. The agreement removes barriers to trade, cuts manufacturers' costs and allows Israeli drugmakers to get their products to the EU market more easily.

BMI Economic View: Israel's economy slowed in H212 and will continue to do so in early 2013, as the government is set to rein in spending, while leading indicator data paint a relatively negative picture for private consumption and fixed investment. As a result, we have lowered down our forecast for 2013 real GDP growth to 3.3%, from a previous forecast of 3.5%.

BMI Political View: The US remains opposed to military action, and there are serious doubts within Israel over the wisdom of a solo Israeli strike. Nevertheless, we cannot rule out an Israeli attack indefinitely, especially if moderates fail to regain political momentum in Iran's June 2013 presidential election.

Report Table of Contents:

BMI Industry View
- Executive Summary
SWOT Analysis
- SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Overall Market Forecast
- Table: Table: Pharmaceutical Sales Indicators 2009-2017
- Healthcare Market Forecast
- Table: Overall Healthcare Expenditure, 2009-2017
- Table: Government Healthcare Expenditure, 2009-2017
- Table: Private Healthcare Expenditure, 2009-2017
- Economic Outlook
- Prescription Drug Market Forecast
- Table: Israel Prescription Drug Market Indicators, Historical Data and Forecasts
- Patented Drug Market Forecast
- Table: Patented Drug Sales, 2009-2017
- Generic Drug Market Forecast
- Table: Generic Drug Sales, 2009-2017
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales, 2009-2017
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Trade, 2009-2017
- Other Healthcare Data Forecasts
- Key Risks To BMI's Forecast Scenario
Industry Risk Reward Ratings
- Pharmaceutical Risk/Reward Ratings
- Table: Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113
Market Overview
- Israel - Market Overview
Industry Trends And Developments
- Table: Table: Israel's R&D Legislation - Conditions For OCS Funding
Regulatory Development
- Regulatory Regime
- Table: Table: Price Build-Up In The Israeli Pharmaceutical Market
Competitive Landscape
Company Profile
- Teva Pharmaceutical Industries
- Taro Pharmaceutical Industries
- Perrigo (Adis Industries)
- Dexcel
- Neopharm
- Trima
- Rekah Pharmaceutical Industry
- Pfizer
- GlaxoSmithKline
- Novartis
- Sanofi
- Merck&Co
Demographic Forecast
- Table: Israel's Population By Age Group, 1990-2020 ('000)
- Table: Israel's Population By Age Group, 1990-2020 (% of total)
- Table: Israel's Key Population Ratios, 1990-2020
- Table: Israel's Rural/Urban Population Split, 1990-2020
Methodology
Methodology
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
- Glossary

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.



BMI View: The UAE continues to take advantage of reduced Iranian volumes to sustain relatively high crude output of around 2.7mn b/d. Including condensates and NGLs, we estimate oil production in 2012 averaged 3.0mn b/d. On the back of efforts to increase recovery rates, we expect UAE production to rise to 3.2mn b/d by 2016. Gas production will also increase as more associated gas is captured and new projects such as the Shah field drive output to 68bcm by the end of our forecast period.

We highlight the following trends and developments in the UAE's oil and gas sector:

* With around 1mn barrels per day (b/d) of Iranian crude removed from the oil market due to sanctions, the UAE is one of the countries taking up the slack - taking advantage of investment in production capacity. Output in mid-2012 averaged around 2.7mn b/d according the latest Independent Energy Agency (IEA) and Energy Information Administration (EIA) data.
* Gas production will continue to grow, with projects such as the Umm Shaif-Habshan project and the Shah development boosting gas output to 67.6bn cubic metres (bcm) by 2016 and 7bcm by 2021. * Despite growing gas volumes, the use of gas in enhanced oil recovery (EOR) projects and extensive processing requirements due to poor quality reserves mean marketable gas volumes are often nearly 40% smaller than the gross volumes actually produced.
* A further 200,000b/d of output was expected by Q412, pushing total production capacity above 3mn b/d. Abu Dhabi is planning to spend US$60bn over the next five years to raise production capacity above 3.5mn b/d. The increase in production capacity has helped support an increase in 2012 oil production; UAE crude output in August 2012 was estimated at 2.7mn b/d.
* The liberalisation of fuel prices is unlikely in the short term, owing to the government largesse following political unrest across the Middle East and North Africa (MENA) region in 2011. Fuels distribution in the UAE will therefore remain a loss-making proposition.


Full Report Details at
- www.fastmr.com/prod/536380_united_arab_emirates_oil_gas_report_q ..


Partial Table of Contents:

BMI Industry View
- BMI Industry View
SWOT
- UAE Oil & Gas SWOT
Industry Forecast
- Industry Forecast
- Industry Forecast Scenario
- Table: Table: UAE Proven Oil and Gas Reserves and Total Petroleum Data - Historical Data And Forecasts, 2010-2016
- Table: Table: UAE Proven Oil and Gas Reserves and Total Petroleum Data - Long-Term Forecasts, 2015-2021
- Table: Table: UAE Oil Production, Consumption and Net Exports - Historical Data And Forecasts, 2010-2016
- Table: Table: UAE Oil Production, Consumption and Net Exports - Long-Term Forecasts, 2015-2021
- Oil Supply and Demand
- Gas Supply And Demand
- Table: Table: UAE Gas Production, Consumption and Net Exports - Historical Data And Forecasts, 2010-2016
- Table: Table: UAE Gas Production, Consumption and Net Exports - Long-Term Forecasts, 2015-2021
- LNG
- Refining And Oil Products Trade
- Table: Table: UAE Refining - Production and Consumption - Historical Data And Forecasts, 2010-2016
- Table: Table: UAE Refining - Production and Consumption - Long-Term Forecasts, 2015-2021
- Revenues/Import Costs
- Key Risks To BMI's Forecast Scenario
Industry Risk/Reward Ratings
- UAE Risk/Reward Rating
- UAE Upstream Rating
- UAE Downstream Rating
- Regional Risk/Reward Ratings
- Table: Oil & Gas Risk/Reward Ratings
- Table: Middle East Downstream Oil & Gas Risk/Reward Ratings
- Table: Middle East Upstream Oil & Gas Risk/Rewards Ratings
Market Overview
- UAE Energy Market Overview
- United Arab Emirates Energy Market Overview
- Overview/State Role
- Licensing And Regulation
- Government Policy
- Fuel Prices
- International Energy Relations
- Oil and Gas Infrastructure
- Oil and Gas Infrastructure
- Oil Refineries
- Table: Refineries In The UAE
- Oil Pipelines
- LNG
- Table: LNG Export Terminals in the UAE
- Gas Pipelines
Competitive Landscape
- Competitive Landscape
Company Profile
- Abu Dhabi National Oil Company (ADNOC)
- Dolphin Energy
- Emirates General Petroleum Corporation (Emarat)
- Emirates National Oil Company (ENOC)
- ExxonMobil
- BP
- Total
- Royal Dutch Shell
- Others Summary
- Rosneft
- KNOC Summary
- Dubai Petroleum Summary
- Dana Gas
- Occidental Petroleum Summary
- INPEX/JPDCO Summary
- Cosmo Summary
- TAQA Summary
- CNPC Summary
- RAK Petroleum Summary
Global Industry Overview
- Regional Energy Market Overview
- Global Energy Market Overview
- Table: Global Oil Demand Forecasts - A Comparison
- Inflection point
- New Frontiers In Production
Appendix
- Regional Appendix
- Table: Table: Oil Consumption - Historical Data & Forecasts, 2009-2016 ('000b/d)
- Table: Table: Oil Consumption - Long-Term Forecasts, 2014-2021 ('000b/d)
- Table: Table: Oil Production - Historical Data & Forecasts, 2009-2016 ('000b/d)
- Table: Table: Oil Production - Long-Term Forecasts, 2014-2021 ('000b/d)
- Table: Table : Refining Capacity - Historical Data & Forecasts, 2009-2016 ('000b/d)
- Table: Table: Refining Capacity - Long-Term Forecasts, 2014-2021 ('000b/d)
-

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=536380&dt=t

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.